Clinical Trials Logo

Clinical Trial Summary

To evaluate whether oral sulfate solution administered in a short time interval (6-8 hours) between the first and last dose of laxative is not inferior to a long time interval (10-12 hours) in bowel preparation quality.


Clinical Trial Description

The split-dose bowel preparation is recommended by multiple guidelines and widely used worldwide for improved bowel preparation quality, higher detection rate of colorectal lesions, and better tolerance. The effect of the time interval between the last dose of laxative and the colonoscopy on the quality of bowel preparation has been well studied, but the impact of the time interval between the first and last dose of laxative on the bowel preparation quality deserve to be explored. Oral sulfate solution administered in a short time interval can reduce sleep disturbance and hunger and is more flexible and convenient. This study aims to evaluate whether oral sulfate solution administered in a short time interval (6-8 hours) is not inferior to a long time interval (10-12 hours) on bowel preparation quality. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06317597
Study type Interventional
Source Changhai Hospital
Contact
Status Enrolling by invitation
Phase Phase 4
Start date March 15, 2024
Completion date December 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT03581175 - Barriers and Breakthroughs in IMPlementing Split Regimen OVEr Single Dose
Completed NCT02287051 - Bowel Prep Acceptance in Clinical Practice N/A